Skip to main content
Top
Published in: BMC Medicine 1/2021

01-12-2021 | Malaria | Research article

Marked reduction in antibiotic usage following intensive malaria control in a cohort of Ugandan children

Authors: Paul J. Krezanoski, Michelle E. Roh, John Rek, Joaniter I. Nankabirwa, Emmanuel Arinaitwe, Sarah G. Staedke, Susan Nayiga, Michelle S. Hsiang, David Smith, Moses Kamya, Grant Dorsey

Published in: BMC Medicine | Issue 1/2021

Login to get access

Abstract

Background

Intensive malaria control may have additional benefits beyond reducing the incidence of symptomatic malaria. We compared antibiotic treatment of children before and after the implementation of highly effective malaria control interventions in Tororo, a historically high transmission area of Uganda.

Methods

Two successive cohorts of children, aged 0.5 to 10 years, were followed from September 2011 to October 2019 in a dedicated study clinic. Universal distribution of long-lasting insecticidal nets was conducted in 2013 and 2017. Sustained indoor residual spraying of insecticide (IRS) was initiated in December 2014. Generalized linear mixed-effects models were used to compare the incidence of antimalarial and antibiotic treatments before and after vector control measures were implemented.

Results

Comparing the period prior to the implementation of IRS to the period after IRS had been sustained for 4–5 years, the adjusted incidence of malaria treatments decreased from 2.68 to 0.05 per person-year (incidence rate ratio [IRR] = 0.02, 95% CI 0.01–0.03, p < 0.001), and the adjusted incidence of antibiotic treatments decreased from 4.14 to 1.26 per person-year (IRR = 0.30, 95% CI 0.27–0.34, p < 0.001). The reduction in antibiotic usage was primarily associated with fewer episodes of symptomatic malaria and fewer episodes of fever with sub-microscopic parasitemia, both of which were frequently treated with antibiotics.

Conclusions

In a historically high transmission setting, the implementation of highly effective vector control interventions was followed by a marked reduction in antibiotic treatment of children. This added benefit of malaria control could have important implications for antibiotic prescribing practices, efforts to curtail antimicrobial resistance, and health system costs.
Appendix
Available only for authorised users
Literature
5.
go back to reference Keitel K, Samaka J, Masimba J, Temba H, Said Z, Kagoro F, et al. Safety and efficacy of C-reactive protein-guided antibiotic use to treat acute respiratory infections in Tanzanian children: a planned subgroup analysis of a randomized controlled noninferiority trial evaluating a novel electronic clinical decision algorithm (ePOCT). Clin Infect Dis. 2019;69(11):1926–34. https://doi.org/10.1093/cid/ciz080 PMID: 30715250.CrossRefPubMed Keitel K, Samaka J, Masimba J, Temba H, Said Z, Kagoro F, et al. Safety and efficacy of C-reactive protein-guided antibiotic use to treat acute respiratory infections in Tanzanian children: a planned subgroup analysis of a randomized controlled noninferiority trial evaluating a novel electronic clinical decision algorithm (ePOCT). Clin Infect Dis. 2019;69(11):1926–34. https://​doi.​org/​10.​1093/​cid/​ciz080 PMID: 30715250.CrossRefPubMed
17.
go back to reference Hopkins H, Bruxvoort KJ, Cairns ME, et al. Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings. BMJ. 2017;356:j1054. https://doi.org/10.1136/bmj.j1054 Erratum in: BMJ. 2017 Jun 29;357:j3168. PMID: 28356302; PMCID: PMC5370398.CrossRefPubMedPubMedCentral Hopkins H, Bruxvoort KJ, Cairns ME, et al. Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings. BMJ. 2017;356:j1054. https://​doi.​org/​10.​1136/​bmj.​j1054 Erratum in: BMJ. 2017 Jun 29;357:j3168. PMID: 28356302; PMCID: PMC5370398.CrossRefPubMedPubMedCentral
Metadata
Title
Marked reduction in antibiotic usage following intensive malaria control in a cohort of Ugandan children
Authors
Paul J. Krezanoski
Michelle E. Roh
John Rek
Joaniter I. Nankabirwa
Emmanuel Arinaitwe
Sarah G. Staedke
Susan Nayiga
Michelle S. Hsiang
David Smith
Moses Kamya
Grant Dorsey
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2021
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-021-02167-2

Other articles of this Issue 1/2021

BMC Medicine 1/2021 Go to the issue